We Succeed Enters Agreement with University of Pennsylvania, Offering Virtual Tutoring Work-Study Program – Yahoo Finance

Work-study students will support K-12 students in a variety of subjects, combatting pandemic learning loss
PHILADELPHIA, September 07, 2021–(BUSINESS WIRE)–Today, We Succeed announced it has entered an agreement with the University of Pennsylvania to offer virtual work-study employment opportunities to students. We Succeed is a virtual tutoring platform created to lessen the educational inequality gap by providing affordable tutoring services to K-12 students. The company employs high-achieving college students receiving financial aid to offer affordable tutoring to K-12 students, boosting the academic and long-term economic success for both.
"This agreement with one of Philadelphia’s most well respected and renowned schools puts us one step closer in fulfilling our mission of creating a world where college students can complete their college education debt-free and K-12 students can access quality educational support regardless of their economic means," said Zahid Mustafa, founder and president of We Succeed. "Since the onset of the COVID-19 pandemic, virtual tutoring has been a critical lifeline to students of all ages. Many college students have realized they can support younger students who need learning support, and do so from the convenience of their home or college dorm. We are honored to welcome University of Pennsylvania students into our program."
Over the past year, more than 97 percent of educators reported seeing some learning loss in their students. We Succeed, which launched in early 2021, seeks to provide a "win-win" approach and solution to tackling educational inequalities by paying college students with financial need a competitive wage while boosting success rates for underserved K-12 students, many of whom have suffered from pandemic learning loss.
The platform, which was developed in conjunction with Saga Education, allows students to work a flexible schedule, with up to 20 hours per week each semester. Students may apply to tutor a range of subjects including: Math, Biology, Chemistry, English/Literacy, History/Social Studies, Physics, Earth Science, Spanish and support for college admissions applications.
The University of Pennsylvania’s work-study program permits students to be employed by off-campus nonprofits and government organizations that enter a formal agreement with the University. As part of this agreement, We Succeed pays a 30-percent matching share of the total wages earned by each student with the other 70 percent paid by work-study funding.
To learn more about We Succeed, please visit www.wesucceed.org.
About We Succeed: We Succeed is a tutoring program that supports both college and K-12 students in need of financial support and quality education. We Succeed aims to provide education for all and boost long-term economic success for society. For more information about We Succeed’s mission, please visit us at https://wesucceed.org/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005063/en/
Contacts
Media:
Olivia Gracey
Gregory FCA
[email protected]
267-884-5803
Shares of fintech leader Block (NYSE: SQ) — the artist formerly known as Square — dropped in Monday morning trading. You can blame investment bank Wedbush for that. Coronavirus worries are tanking the stock market this morning, and coronavirus worries make up a big part of why Wedbush just cut its price target on Block stock by 24%, to $190 a share.
The Chinese e-commerce giant unveiled a turnaround plan last week, but didn't impress enough to overcome current fears.
In this article, we’ll discuss Jim Cramer’s most favorite tech stocks to buy now. You can skip our detailed analysis of Cramer’s background and tech stocks, and go directly to read Jim Cramer’s 5 Most Favorite Tech Stocks to Buy Now. Jim Cramer is one of the most prominent names in the investment world. His […]
It's not only the spread of the omicron COVID-19 variant that has investors worried about the fuel cell industry.
AT&T Inc. (NYSE:T) was a rare outperformer last week after Morgan Stanley analyst Simon Flannery upgraded his rating on the stock from ‘equal-weight’ to overweight. The stock gained 6.95% on Thursday, its biggest one day gain in months – although the stock price is still down nearly 20% for the year. Flannery said price weakness had created an opportunity and upgraded his rating, though he lowered the price target from $32 to $28.
Shares of Nio (NYSE: NIO) set their all-time high back on Jan. 11, when they traded at $66.99 at some point during the day. Clearly it has been a rough year for Nio, which has been hit by COVID-19 shutdowns, supply chain challenges, and a lull in its new-product cycle that allowed competitors to gain ground. Nio will begin shipping its long-awaited ET7 sedan in March, followed in September by the one-size-down ET5, which was revealed on Saturday. Meanwhile, its order books remain strong, its customer satisfaction is high, and there are signs that it may have put the worst of the supply chain woes in the rearview mirror.
Shares of Chilean lithium mining stock Sociedad Quimica y Minera (NYSE: SQM) melted down on Monday, down 13% as of 10:30 a.m. ET. You can blame Bank of America for that — and the voters of the nation of Chile. Yesterday, in a historic upset, former Chilean student activist Gabriel Boric was elected Chile's new president — and at just 35 years of age, the youngest and least experienced president in Chilean history.
While there's no way to know for sure if a given stock has what it takes to outperform, looking at a company's upcoming catalysts is one trick that can help to stack the deck in your favor. Catalyst Pharmaceuticals (NASDAQ: CPRX) makes a drug called Firdapse for Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder. Since the drug's first sales in 2019, the company's quarterly revenue has exploded by a shocking 7,090%.
After a disastrous 2020, The Boeing Company (NYSE: BA) spent 2021 restructuring and unwinding the 747 MAX aftermath. Yet, even though the company will likely double the deliveries Y/Y, the stock significantly underperformed the market, with few large institutional investors recently trimming their stakes.
Vaccine stocks Moderna and Novavax fell Monday despite bullish news for their Covid vaccines as omicron cases continue rising.
With the price of silver slipping to start the week, shares of Fortuna Silver Mines (NYSE: FSM) are headed in the opposite direction. The company announced today that it has received a permit from the Mexican government for its silver-gold asset, San Jose, and Wall Street is reacting to the news today. As of 10:22 a.m. ET on Monday, shares of Fortuna Silver Mines were up 17.4%.
These stocks are caught in a general stock market downturn, but there are also questions about the cannabis market itself.
The folks at Bespoke say the day after an ugly Monday selloff, with drops of at least 1%, tend to be followed by a comparatively strong Tuesday performance.
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the World Health Organization (WHO) has granted a second Emergency Use Listing (EUL) for NVX-CoV2373, Novavax' recombinant protein nanoparticle COVID-19 vaccine with Matrix-M™ adjuvant, for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. Today's EUL pertains to vaccine to be marke
BP Midstream's parent came calling, and a deal has finally been hammered out. Here's a quick look.
Here are three growth stocks that will skyrocket 50% or more in 2022, according to Wall Street. The consensus 12-month price target for Sea Limited (NYSE: SE) reflects an upside potential of 89%. Sea's past success has been primarily driven by its Free Fire mobile game.
The two-dose protein-based vaccine, branded Nuvaxovid, is the fifth coronavirus vaccine recommended by the EU.
Shares of Chinese electric-vehicle maker Nio (NYSE: NIO) were trading down on Monday morning, amid a broad stock market sell-off driven by concerns about the highly contagious omicron variant of COVID-19. As of 10:30 a.m. ET, Nio's American depositary shares were down about 3.4% from Friday's closing price. The company unveiled its second electric luxury-sports sedan, called the ET5, at its annual Nio Day event on Saturday.
(Bloomberg) — President Recep Tayyip Erdogan’s government announced extraordinary measures to bolster the Turkish lira, including the introduction of a new program that will protect savings from fluctuations in the local currency.Most Read from BloombergModerna’s Third Dose Boosts Antibodies Against OmicronS&P 500 Has Biggest Three-Day Drop Since September: Markets WrapSouth Africa Cases Slow; Quebec Closes Bars, Gyms: Virus UpdateEurope Braces for More Covid Lockdowns as U.K. Cases SurgeSouth
The stock I like in the renewable power space isn't a renewable power stock, but don't let that fool you. The high yielder will be eventually.

source

- Advertisement -spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here